Blood Tumor Mutational Burden as a Predictive Biomarker in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC). Pjmcr [Internet]. 2026 May 19 [cited 2026 Jul. 5];5(2):2361-9. Available from: https://pakjmcr.com/index.php/1/article/view/1041